¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Intermediate lesions of pinta"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pinta
    ¿­´ë¹é¹ÝÇǺο°, ÇÉŸ
  • red pinta
    Àû»öÇÉŸ
  • intermediate
    1. Áß°£- 2. Áß°£¹°
  • intermediate body
    Áß°£¼Òü
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹éÁú
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nerve
    Áß°£½Å°æ
  • intermediate product
    Áß°£»ê¹°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate
    Áß°£-, Áß°£¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pinta
    ¿­´ë¹é¹ÝÇǺο°, ÇÉŸ
  • red pinta
    Àû»öÇÉŸ
  • intermediate body
    Áß°£¼Òü
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate hybrid
    Áß°£ÀâÁ¾
  • intermediate
    Áß°£-, Áß°£¹°
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nephron
    Áß°£ÄáÆÏ´ÜÀ§
  • intermediate nerve
    Áß°£½Å°æ
  • intermediate product
    Áß°£»ê¹°, Áß°£´ë»ç¹°
  • intermediate ray
    Áß°£¹æ»ç¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary vascular lesions
    ¿ø¹ß(¼º) Ç÷°ü°è º´º¯
  • pinta
    ÇÉŸ
  • pinta
    ÇÉŸ, ¿­´ë¹é¹Ý¼º ÇǺο°(æðÓáÛÜÚèàõ ù«Ý±æú)
  • red pinta
    Àû»öÇÉŸ
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate filaments
    Áß°£¼¼»ç(ñéÊàá¬Þê)
  • Intermediate part(commissura) of bulb
    Áú¾î±Í¸Á¿ïÁß°£ºÎºÐ
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
  • pituitary intermediate lobe
    ³úÇϼöüÁß°£¿±, ³úÇϼöüÁß¿±(¡­ñéç¨).
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • reactive intermediate
    ¹ÝÀÀ¼º Áß°£¹°Áú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blue pinta
    û»ö ÇÉŸ
  • carate = pinta
  • pinta
    ÇÉŸ
  • pinta
    ÇÉŸ, ¿­´ë¹é¹Ý¼º ÇǺο°(æðÓáÛÜÚèàõ ù«Ý±æú)
  • red pinta
    Àû»öÇÉŸ
  • epileptogenic lesions
    °£Áú¾çº´º¯.
  • intestine, large,obstructive lesions
    ¼º º´º¯(øÍáðàõ ܻܨ)
  • primary vascular lesions
    ¿ø¹ß(¼º) Ç÷°ü°è º´º¯
  • skin lesions
    ÇǺκ´º¯(¡­Ü»Ü¨)
  • squamous intraepithelial lesions
    ÆíÆò¼¼Æ÷ »óÇdz»º´º¯
  • target lesions
    Ç¥Àûº´¼Ò, °ú³áº´¼Ò, ŸÄÉÆ®º´¼Ò
  • central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
  • intermediate
    Áß°£(ñéÊà)ÀÇ, Áß°£¹°(ñéÊàÚª).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • (Intermediate lacunar node)
    (Áß°£Ç÷°üÄ­¸²ÇÁÀý)
    [¿¾ ¿ë¾î] Áß°£¿ä¿ÍÀÓÆÄÀý
  • Lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£Áú¿ÜÃøºÎ
  • Gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] °Å´ë¼¼Æ÷Áß°£¸Á»óüÇÙ
  • Posterior intermediate sulcus
    µÚÁß°£°í¶û
    [¿¾ ¿ë¾î] ÈÄÁß°£±¸
  • Medullary intermediate reticular nucleus
    ¼û³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] ¿¬¼öÁß°£¸Á»óüÇÙ
  • Intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁß°£ºÎ
  • Inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] Çϱ³³úÁß°£¸Á»óüÇÙ
  • Superior pontine intermediate reticular nucleus
    À§´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] »ó±³³úÁß°£¸Á»óüÇÙ
  • Intermediate
    Áß°£
    [¿¾ ¿ë¾î] Áß°£
  • Intermediate branch
    Áß°£°¡Áö
    [¿¾ ¿ë¾î] Áß°£Áö
  • Intermediate hepatic veins
    Áß°£°£Á¤¸Æ
    [¿¾ ¿ë¾î] Áß°£Á¤¸Æ
  • Intermediate zone
    Áß°£±¸¿ª
    [¿¾ ¿ë¾î] Áß°£´ë
  • Intermediate line
    Áß°£´É¼±
    [¿¾ ¿ë¾î] Áß°£¼±
  • Intermediate lymph nodes
    Áß°£¸²ÇÁÀý
    [¿¾ ¿ë¾î] Áß°£ÀÓÆÄÀý
  • Intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
    [¿¾ ¿ë¾î] Áß°£°æºÎÁß°Ý
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first intermediate host
    Á¦ÀÏÁß°£¼÷ÁÖ
  • intermediate host
    Áß°£¼÷ÁÖ
  • second intermediate host
    Á¦ÀÌÁß°£¼÷ÁÖ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • common intermediate principle
    °øÅë Áß°£Ã¼¿ø¸®(Íì÷×ñéÊàô÷ê«×â)
  • covalent intermediate
    °øÀ¯°áÇÕ Áß°£»ê¹°(ÍìêóÌ¿ùêñéÊàß§Úª)
  • enzyme-substrate intermediate
    È¿¼Ò-±âÁú Áß°£Ã¼ (ý£áÈÐñòõñéÊàô÷)
  • intermediate
    Áß°£¹°(ñéÊàÚª)
  • lipid intermediate
    ÁöÁúÁß°£´ë»ç¹°(ò·òõñéÊàÓÛÞóÚª)
  • tetrahedral intermediate
    »ç¸éüÇü Áß°£´ë»ç¹° (ÞÌØüô÷û¡ñéÊàÓÛÞóÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate
    Áß°£ÀÇ, Áß°£¹°
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate nerve
    Áß°£½Å°æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FACES unique facies, anorexia, cachexia, and eye and skin lesions [syndrome]
IDL Index to Dental Literature; interface definition language; intermediate density lipoprotein; interme...
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen...
IM idiopathic myelofibrosis; immunosuppressive method; implementation monitoring; Index Medicus; indome...
CLIP Corticotropin-Like Intermediate Peptide
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CAL Coronary artery lesions
SOL Space Occupying Lesions
WML White matter lesions
ERGIC ER Golgi intermediate compartment
I Intermediate
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • A67.1
    Intermediate lesions of pinta
    Áß°£ º´ÅÍÀÇ ÇÉŸ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pinta ºñ¼ºÀûÀ¸·Î ÀüÆÄµÇ¾îÁö´Â spirochectal °¨¿°À¸·Î¼­ Treponema carateum¿¡ ÀÇÇØ ¹ß»ýµÈ´Ù. ÁÖ·Î ¶óƾ ¾Æ¸Þ¸®Ä«ÀÇ Áö¹æ, ¸ß½ÃÄÚ, ÄÝ·Òºñ¾Æ, Äí¹Ù, ÅÂÆò¾ç ÁÖº¯ÀÇ ¸î¸î Áö¿ª¿¡¼­ ¹ß»ýµÈ´Ù. ¹«±Ë¾ç¼º, È«¹Ý¼ºÀÇ ÀÏÂ÷¼º ±¸ÁøÀÌ ¿©·¯ »ö±ò º¯È­¿Í ÇÔ²² ±¸ÁøÆíÆò»óÇǼºÀÇ ÆÇÀ»
    Áö¹æ°è
    °è±â»ó¿¡ ±×·ÁÁ® ÀÖ´Â 6°¡ÁöÀÇ À½¿µ°ú ºñ»öÇÏ¿© ¿ìÀ¯ ÁßÀÇ Áö¹æ·®À» ÃßÁ¤ÇÏ´Â °è±â.
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • intermediate
    Áß°£ÀÇ, Áß°£¹°, Áß°£Ã¼, Áß°£¹°Áú
    1. ¾ç±Ø´ÜÀÇ ½Ö¹æ¿¡ ÀϺΠÀ¯»çÇÑ. 2. ¹ÝÀÀÀÇ ÃÖÁ¾ »ê¹° Çü¼º¿¡ ÇʼöÀûÀÎ È­ÇÐ ¹ÝÀÀÀÇ °úÁ¤ Áß¿¡ ¸¸µé¾îÁö´Â ¹°Áú.
  • intermediate body of Flemming
    Ç÷¹¹Ö Áß°£Ã¼
    À¯»ç ºÐ¿­ÀÇ ÃÖÁ¾ ´Ü°è¿¡ À־ µÎ °³ÀÇ ³¶ ¼¼Æ÷¸¦ ¿¬°á½ÃŰ´Â È£»ê¼º ¹°ÁúÀÇ ÀÛÀº Áö¸§ ´Ù¸®.
  • intermediate cell
    Áß°£ ¼¼Æ÷
    ÁßÃþ ÆíÆò »óÇÇ Á¶Á÷ÀÇ Áß°£Ãþ, ÁÖ·Î °ú¸³ ¼¼Æ÷ÃþÀ» Â÷ÁöÇÏ´Â ¼¼Æ÷·Î¼­ ¼¼ Æ÷Áø¿¡¼­´Â Ç¥Ãþ ¼¼Æ÷º¸´Ù ¾à°£ ÀÛ¾Æ 30-50 ¸¶ÀÌÅ©·Î¹ÌÅÍÀÇ ´Ù°¢ÇüÀ̳ª À¯¿øÇüÀÇ ¿¯Àº ¼¼Æ÷ÁúÀ» Áö´Ñ ÆíÆòÇÑ ¼¼Æ÷. ÇÙÀº ¼¼Æ÷ÀÇ Á߽ɿ¡ ÀÖÀ¸¸ç, Ç¥Ãþ ¼¼Æ÷º¸´Ù´Â ¾à°£ Å©°í, ¼ÒÆ÷»óÀÇ ÇÙ³» ±¸Á¶¸¦ °üÂûÇÒ ¼ö ÀÖ´Ù.
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • intermediate junction
    ºÎÂø ¶ì
    µ¿ÀǾî=zonula adherens. Æó¼â ¶ìó·³ ¼¼Æ÷¸¦ ¿ÏÀüÈ÷ µÑ·¯ ½Î¸ç Æó¼â ¶ìÀÇ ¹Ù·Î ¾Æ·¡¿¡ À§Ä¡ÇÑ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆøÀÌ 20-25§¬ÀÎ ÀÏÁ¤ÇÑ °ø°£ÀÌ Á¸ÀçÇϴµ¥ ÀÌ °ø°£Àº ÀüÀÚ ¹Ðµµ°¡ ³·¾Æ °ÅÀÇ Åõ¸íÇÏ°Ô º¸À̸ç ÀÌ ¾È¿¡ µé¾î ÀÖ´Â ¹°ÁúÀÌ µÎ °³ÀÇ ÇüÁú¸· ºÎÂø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¹Ï¾îÁö³ª ¾ÆÁ÷ ¾î¶² ¹°ÁúÀÎÁö´Â ¹àÇôÁ® ÀÖÁö ¾Ê´Ù.
  • intermediate movement
    Áß°£ ÇÏ¾Ç ¿îµ¿
    ÇϾǰñÀÌ ¿îµ¿ÇÒ ¼ö ÀÖ´Â ÃÖ´ëÀÇ ¿îµ¿ ¹üÀ§ ³»¿¡¼­ ÀϾ´Â ¸ðµç ¿îµ¿.
  • intermediate syndrome
    Áß°£Çü ÁõÈıº
  • intermediate zone
    Áß°£´ë, Áß¾ÓºÎ, °üÀý ¿øÆÇ Áß°£ºÎ
  • lateral intermediate substance
    °¡ÂÊ Áß°£ ȸ»öÁú
  • replicative intermediate
    º¹Á¦ Áß°£Çü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
pinta An infectious disease of the skin caused by treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterised by marked changes in the skin colour and is believed to be transmitted by direct person-to-person contact.
(12 Dec 1998)
pinta fever A term used in Mexico for Rocky Mountain spotted fever.
(05 Mar 2000)
ring lesions in brain <radiology> Hypodense, peripherally enhancing lesions, ** mnemonic: MAGIC DR., metastasis, abscess, glioma, granuloma, infarct, contusion, demyelination, resolving haematoma
(12 Dec 1998)
circumscribed breast lesions <radiology> Lucent, lipoma, oil cyst (following haematoma or biopsy), galactocele (associated with lactation), mixed density, fibro-adeno-lipoma, galactocele, intramammary lymph node, haematoma
(12 Dec 1998)
cold bone lesions <radiology> Overlying atenuation caused by pacemaker, barium, metal cross, wristwatch, radiation therapy, local vascular compromise, early osteomyelitis, tumour: neuroblastoma, renal cell carcinoma, thyroid carcinoma, anaplastic tumours (e.g. Reticulum cell sarcoma)
(12 Dec 1998)
polypoid gallbladder lesions <radiology> Cholesterol polyp, adenoma, papilloma (usually less than 1 cm, may be premalignant), carcinoma, metastasis, adenomyomatosis, tumefactive sludge, inflammatory polyp
(12 Dec 1998)
hot bone lesions <radiology> Non-routine localised hot bone lesions: Paget's disease, osteoid osteoma, fibrous dysplasia, melorheostosis generalised: hyperparathyroidism, haematologic disorders, Paget disease (rare), fibrous dysplasia, renal osteodystrophy
(12 Dec 1998)
skin lesions of tuberous sclerosis <radiology> Adenoma sebaceum, Shagreen patches, periungual fibromata, ash-leaf hypopigmentation
(12 Dec 1998)
stellate breast lesions <radiology> Scirrhous carcinoma (infiltrating ductal carcinoma), small (baby) scirrhous carcinoma, sclerosing ductal hyperplasia, traumatic fat necrosis, hyalinised fibroadenoma
(12 Dec 1998)
target lesions of liver/spleen <radiology> Lymphosarcoma (including Kaposi sarcoma), melanoma
(12 Dec 1998)
large breast lesions <radiology> Breast masses greater than 5 cm, lucent: lipoma, mixed lucent/opaque: fibro-adeno-lipoma, low-density opaque: giant fibroadenoma, cyst, cystosarcoma phylloides, mucinous carcinoma, high-density opaque (large and dense)
(12 Dec 1998)
large, dense breast lesions <radiology> Carcinoma, sarcoma, cystosarcoma phylloides, cyst, abscess, lymph nodes (lymphoma, leukaemia, metastasis)
(12 Dec 1998)
anterior intermediate groove A furrow occasionally seen in the adult between the anterior median fissure and the anterior lateral sulcus of the spinal cord but usually present only in the foetus. It indicates the lateral border of the anterior corticospinal fasciculus.
Synonym: anterior intermediate groove, sulcus intermedius anterior.
(05 Mar 2000)
anterior intermediate sulcus A furrow occasionally seen in the adult between the anterior median fissure and the anterior lateral sulcus of the spinal cord but usually present only in the foetus. It indicates the lateral border of the anterior corticospinal fasciculus.
Synonym: anterior intermediate groove, sulcus intermedius anterior.
(05 Mar 2000)
ganglion of intermediate nerve The sensory ganglion of the facial (7th cranial) nerve. The geniculate ganglion cells send central processes to the brainstem and peripheral processes to the taste buds in the anterior tongue, the soft palate, and the skin of the external auditory meatus and the mastoid process.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate
    Áß°£¿¡ ÀÖ´Â
  • intermediate
    Áß°£ÀÇ;°³ÀçÇÏ´Â;Áß°£¿¡ ÀϾ´Â;Áß°£¹°;ÁßÀç(Áß°³)ÀÚ Áß°£½ÃÇè;ÁßÇüÂ÷;»çÀÌ¿¡ µé¾î°¡´Ù;ÁßÀçÇÏ´Ù;Áß°³ÇÏ´Ù
  • intermediate frequency
    Áß°£Á֯ļö
  • intermediate host
    Áß°£¼÷ÁÖ(±â»ýÃæÀÇ À¯»ý±âÀÇ ¼÷ÁÖ)
  • intermediate range ballistic missile
    Á߰Ÿ® ŸµµÅº
  • intermediate school
    ÁßÇб³;(¹Ì)±¹¹ÎÇб³4-6Çг⠰úÁ¤ÀÇ Çб³;(¿µ)±¹¹ÎÇб³ »ó±Þ°ú ÁßÇб³ÀÇ Áß°£Çб³(12-14¼¼ ÇлýÀ» ¼ö¿ë)
  • intermediate technology
    Áß°£ °øÇÐ(¼Ò±Ô¸ðÀûÀÌ°í °£´ÜÇÑ ¹æ¹ýÀ̳ª ±â¼úÀ» Çö´ëÀÇ Ã·´Ü ±â¼úÀ̳ª ±â°è¿¡ °áºÎ½ÃŲ °øÇÐ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á